Vlahcevic Z R, Pandak W M, Hylemon P B, Heuman D M
Section of Gastroenterology, McGuire Veterans Administration Medical Center, Richmond, Virginia.
Hepatology. 1993 Sep;18(3):660-8.
Cholesterol 7 alpha-hydroxylase, the rate-limiting enzyme in the bile acid biosynthetic pathway, is thought to be regulated by hydrophobic bile acids through negative feedback control. The role of cholesterol in the regulation of cholesterol 7 alpha-hydroxylase is more controversial, in part because of incomplete understanding of the relationship between the pathways of cholesterol synthesis and degradation. The main objective of this study was to define the interaction between these two pathways in an experimental model in which the supply of newly synthesized cholesterol was interrupted by sustained infusion of mevinolin (lovastatin), an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMG-CoA reductase) or accelerated by a continuous infusion of mevalonate, a cholesterol precursor. The study was carried out in rats subjected to short-term bile fistula. In one set of experiments, rats were treated postoperatively with mevinolin (5 mg/kg loading dose followed by 2 mg/kg/hr infusion), mevalonate (180 mumol/hr infusion) or both for up to 96 hr. In a separate set of experiments, rats were infused intraduodenally with taurocholate (36 mumol/100 gm/hr for up to 96 hr). We determined cholesterol 7 alpha-hydroxylase- and HMG-CoA reductase specific activities at those time intervals, whereas bile acid synthesis rates were determined throughout the study. Compared with rats not subjected to surgery, rats with short-term biliary diversion had increases in cholesterol 7 alpha-hydroxylase activity of 259% and 827% at 48 and 96 hr, respectively. The increase in bile acid biosynthesis was less pronounced. Continuous infusion of mevinolin completely prevented increases in cholesterol 7 alpha-hydroxylase specific activity and bile acid biosynthesis at both time intervals.(ABSTRACT TRUNCATED AT 250 WORDS)
胆固醇7α-羟化酶是胆汁酸生物合成途径中的限速酶,被认为受疏水性胆汁酸通过负反馈控制进行调节。胆固醇在胆固醇7α-羟化酶调节中的作用更具争议性,部分原因是对胆固醇合成与降解途径之间的关系理解不完整。本研究的主要目的是在一个实验模型中确定这两条途径之间的相互作用,在该模型中,新合成胆固醇的供应通过持续输注美伐他汀(洛伐他汀)(一种3-羟基-3-甲基戊二酰辅酶A还原酶(HMG-CoA还原酶)抑制剂)而中断,或通过持续输注胆固醇前体甲羟戊酸而加速。该研究在接受短期胆瘘的大鼠中进行。在一组实验中,大鼠术后接受美伐他汀(5mg/kg负荷剂量,随后以2mg/kg/小时输注)、甲羟戊酸(180μmol/小时输注)或两者联合治疗长达96小时。在另一组单独的实验中,大鼠十二指肠内输注牛磺胆酸盐(36μmol/100g/小时,长达96小时)。我们在这些时间间隔测定胆固醇7α-羟化酶和HMG-CoA还原酶的比活性,而在整个研究过程中测定胆汁酸合成速率。与未接受手术的大鼠相比,短期胆汁转流的大鼠在48小时和96小时时胆固醇7α-羟化酶活性分别增加了259%和827%。胆汁酸生物合成的增加不太明显。持续输注美伐他汀完全阻止了两个时间间隔内胆固醇7α-羟化酶比活性和胆汁酸生物合成的增加。(摘要截断于250字)